Jongthawin, J.; Naowaratwattana, W.; Thanasai, J.; Puangpronpitag, D.; Dokduang, H.; Phosuk, I.; Daiponmak, W.
Clinical Outcomes of the Germline RET M918T Pathogenic Variant in Hereditary Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis. Medicina 2026, 62, 1636.
https://doi.org/10.3390/medicina62091636
AMA Style
Jongthawin J, Naowaratwattana W, Thanasai J, Puangpronpitag D, Dokduang H, Phosuk I, Daiponmak W.
Clinical Outcomes of the Germline RET M918T Pathogenic Variant in Hereditary Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis. Medicina. 2026; 62(9):1636.
https://doi.org/10.3390/medicina62091636
Chicago/Turabian Style
Jongthawin, Jurairat, Wanlaya Naowaratwattana, Jongkonnee Thanasai, Darunee Puangpronpitag, Hasaya Dokduang, Issarapong Phosuk, and Wipavadee Daiponmak.
2026. "Clinical Outcomes of the Germline RET M918T Pathogenic Variant in Hereditary Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis" Medicina 62, no. 9: 1636.
https://doi.org/10.3390/medicina62091636
APA Style
Jongthawin, J., Naowaratwattana, W., Thanasai, J., Puangpronpitag, D., Dokduang, H., Phosuk, I., & Daiponmak, W.
(2026). Clinical Outcomes of the Germline RET M918T Pathogenic Variant in Hereditary Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis. Medicina, 62(9), 1636.
https://doi.org/10.3390/medicina62091636
